Chennai: The direct sales company Amway has placed India in one of the three main priority markets globally, along with the United States and China.
“In terms of sales, India is in the top 10, and in terms of long-term investment and growth, it is one of the top three, along with the US and China,” said global pants, Amway.
The company has plants in these three markets and most of the $ 300 million global investment will come to India.
“We invest in manufacturing, in product development, organic agriculture, social media, and marketing,” he added.
Amway has announced an investment of more than $ 20 million (RS 170 Crore) to improve research and development, manufacturing automation, innovation & science and strengthen digital capabilities in India.
Critical to the India Story is Amway’s Foray to the Ayurveda segment with its Nutrilite brand.
Amway, the frayed Ayurveda with Chawansprash Nutrilite earlier this year, will add more products to make the Ayurveda range of their health components.
“Our plan is to provide a holistic health solution and we want to use the knowledge of Ayurveda and Charak Samhita and combine them with the efficacy of science and botany, so there will be more upcoming products.” For Amway, Ayurveda is a “long-term trip” and the company will “invest in organic agricultural partnerships, botany and alliances” with the top university (recently tied with IIT Mumbai).
The reason Ayurveda aggression is clear – from “very low percentiles, Ayurveda products now 8-10% of our sales turnover,” Pant said.
The company focuses on “preventive health” where “Ayurveda wisdom is very critical”.
The company, which has just started exports with Indonesia, also plans to be aggressive on the front.
“Even during a pandemic with all the interference, we have initiated exports to Indonesia and we will continue to grow especially to Southeast Asia,” Pant said.